CSIMarket Company Name, Ticker, Suppliers, else..


Bioxcel Therapeutics Inc   (NASDAQ: BTAI)
Other Ticker:  
 

Bioxcel Therapeutics Inc

BTAI's Fundamental analysis



Bioxcel Therapeutics Inc 's sales fell by -2.66 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 942

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Bioxcel Therapeutics Inc net loss decreased from $-22 millions, to $-11 millions in fourth quarter of 2024,

• More on BTAI's Growth


Bioxcel Therapeutics Inc
realized a net loss in trailing twelve months.

Bioxcel Therapeutics Inc realized cash reduction of $ -13.95 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.6.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.


• More on BTAI's Valuation
 
 Total Debt (Millions $) 103
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 19,534
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.85
 Tangible Book Value (Per Share $) -36.73

Bioxcel Therapeutics Inc
realized net loss in trailing twelve months.

Bioxcel Therapeutics Inc realized cash outflow of $ -13.95per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.6.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.02.


• More on BTAI's Valuation

•  Market Capitalization (Millions $) 4
•  Shares Outstanding (Millions) 3
•  Employees 116
•  Revenues (TTM) (Millions $) 2
•  Net Income (TTM) (Millions $) -60
•  Cash Flow (TTM) (Millions $) -35
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 103
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 19,534
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 6.85
•  Tangible Book Value (Per Share $) -36.73

•  Market Capitalization (Millions $) 4
•  Shares Outstanding (Millions) 3
•  Employees 116
•  Revenues (TTM) (Millions $) 2
•  Net Income (TTM) (Millions $) -60
•  Cash Flow (TTM) (Millions $) -35
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 1.68
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.04
•  Inventory Turnover Ratio (TTM) 1.17





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com